Capoten, the company's heart drug, rose 13 percent, to $385 million.

Yet the patients often continue to see heart specialists and take heart drugs unnecessarily.

The heart drug will have $1.42 billion in 1993 sales, down sharply from $1.67 billion in 1992, he said.

A study finds that one heart drug is far more effective than another.

In 1981 colleagues found out that he was inventing data on a heart drug.

To control the disorder, the doctors prescribed large doses of propranolol, a standard heart drug.

But just one product, a heart drug called Tenormin, made up a third of its drugs sales last year, and this treatment faces new competition.

Continue taking a heart drug even if you feel better; stopping medications suddenly can make your condition worse.

A leading pharmaceutical company announced yesterday that it would give all its heart drugs free to patients who cannot afford them.

The company can also develop gene therapies, like its heart drug.